Endometrioid adenocarcinoma of the ovary and long-term tamoxifen therapy: A coincidence or a cause for concern?

European Journal of Gynaecological Oncology

Volumn 18, Issue 6, 1997, Pages 457-460

  Yi Shin Kuo, D ^a   Jones, J ^b   Fields, A L ^a   Runowicz, C D ^a   Goldberg, G L ^a,b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

AGED; ARTICLE; BREAST CANCER; CASE REPORT; ENDOMETRIOID CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; POSTMENOPAUSE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARCINOMA, ENDOMETRIOID; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; OVARIAN NEOPLASMS; TAMOXIFEN;

EID: 0030700702     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Sutherland R. L., Jordan V. C.: "Non-steroidal antioestrogens". Sidney, Academic Press, 1981.
2. Mouridsen H., Palshof T., Patterson J., Battersby L.: "Tamoxifen in advanced breast cancer". Cancer Treat. Rev., 1978, 5, 131.
3. Kuo D Y. S., Runowicz C. D.: "The gynecologic effects of tamoxifen". Med. Oncol., 1995, 12, 87.
4. Boccardo F., Bruzzi P., Rubagatti A., Nicolo G., Rosso R.: "Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients". Oncology, 1981, 38, 281.
5. Eells T. P., Alpern H. D., Grzywacz C., MacMillan R. W., Olson J. E.: "The effect of tamoxifen on cervical squamous maturation in Papanicolaou stained cervical smears of post-menopausal women". Cytopathology, 1990, 1, 263.
6. Nuovo M. A., McCaffrey R. M , Levine R. U., Barron B., Winkler B.: "Endometrial polyps in post menopausal patients receiving tamoxifen". Int. J. Gynecol. Pathol., 1989, 81, 125.
7. Corley D., Rowe J., Curtis M. T , Hogan W. M., Noumoff J. S., LiVolsi V. A.: "Post menopausal bleeding from unusual endometrial polyps in women receiving tamoxifen therapy, a case report". Br. J. Obstet. Gynecol., 1990, 97, 190.
8. DeMuylder X., Neven P., DeSomer M., Van Belle Y., Vanderick G , DeMuylder E.: "Endometrial lesions in patients undergoing tamoxifen therapy". Int. J. Gynecol. Obstet , 1991, 36, 127.
9. Ford M. R. W., Turner M. J., Wood C., Sauttcr W.: "Endometriosis developing during tamoxifen therapy". Am. J. Obstet. Gynecol., 1988, 158, 119.
10. Dilts P. V. Jr., Hopkins M. P., Chang A., Cody R. L.: "Rapid growth of leiomyoma in patient receiving tamoxifen". Am. J Obstet. Gynecol., 1992, 166, 167.
11. Cross S. S., Ismail S. M.: "Endometrial hyperplasia in oophorectomized women receiving tamoxifen therapy, case report". Br. J Obset. Gynecol., 1990, 97, 190
12. Gal D., Kopel S., Bashevkin M., Lebowicz J., Lev R., Tancer M. L.: "Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer - preliminary report". Gynecol. Oncol., 1991, 42, 120.
13. Killackey M. A , Hakes T. B., Pierce V. K.: "Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens". Cancer Treat. Rep., 198, 69, 237.
14. Fornander T., Cedermark B., Mattsson A., Skoog L., Theve T., Askergren J. et al.: "Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancer". Lancet, 1989, 2, 117
15. Andersson M., Storm H. H., Mouridsen H. T.: "Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer". J. Natl. Cancer Inst., 1991, 83, 1013.
16. Fisher B., Constantino J. P., Redmond C. K., Fisher E. R., Wickerham D. L., Cronin W. M. and other NSABP contributors: "Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14". J Natl. Cancer Inst., 1994, 86, 527.
17. Malfetano J. H.: "Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients". Gynecol. Oncol., 1990, 39, 82.
18. Fornander T., Hellstrom A. C., Moberger B.: "Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer". J. Natl. Cancer Inst., 1993, 85, 1850.
19. Jolies C. J., Smotkin D., Ford K. L., Jones K.P.: "Cystic ovarian necrosis complicating tamoxifen therapy for breast cancer in a premenopausal women". J. Reprod. Med., 1990, 35, 299.
20. Barhieri R. L., Ferraci A. L., Droesch J. N., Rachelson B. L.: "Ovarian torsion in a premenopausal women treated with tamoxifen for breast cancer". Fertil. Steril., 1993, 59, 459.
21. Shulman A., Cohen I., Altaras M., Maymon R., Ben-Nun I., Tepper R. et al : "Ovarian cyst formation in two pre-menopausal patients treated with tamoxifen for breast cancer". Human Reprod., 1994, 9, 1427.
22. Re A., Wierdis T., Tessarolo M., Leo L., Bellino R., Lauricella A et al.: "Two cases of ovarian cysts in postmenopausal patients under antiestrogen treatment" Clin. Exptl. Obstet. Gynecol., 1994, 21, 221.
23. Willemsen W., Kruitwagen R., Bastiaans B., Hanselaar T., Rolland R.: "Ovarian stimulation and granulosa-cell tumour". Lancet. 1993, 341, 986.
24. Balasch J., Barri P. N.: "Follicular stimulation and ovarian cancer". Human Reprod., 1993, 8, 990.
25. Whittemore A. S., Harris R., Itnyre J : "Collaborative ovarian cancer group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women". Am. J. Epidemiol., 1992, 136, 1184.
26. Harris R., Whittemore A. S , Itnyre J.: "Collaborative ovarian cancer group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women". Am. J. Epidemiol., 1992, 136, 1204.
27. Rossing M. A., Daling Jr. Weiss N. S., Moore D. E., Self S. G.: "Ovarian tumors in a cohort of infertile women". N. Engl J Med., 1994, 331, 771.
28. Messinis I. E., Nillius S J.: "Comparison between tamoxifen and clomiphene for induction of ovulation". Acta Obstet. Gynecol. Scand., 1979, 61, 398.
29. Cohen I., Altaras M. M., Lew S , Tepper R., Beyth Y., Ben-Baruch G., "Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature" Gynecol. Oncol. 1994, 55, 443.
30. Eeles R. A., Stratton M. R , Goldgar D. E., Easton D. F : "The genetics of familial breast cancer and their practical implications" Eur. J. of Cancer, 1994, 30A, 1383.
31. Lynch H. T., Watson P., Lynchg J. F., Conway T. A., Fili M.: "Hereditary ovarian cancer, heterogeneity in age at onse". Cancer, 1993, 71, 573.
32. Gallion H. H., Smith S. A.: "Hereditary ovarian carcinoma". Seminars in Surg. Oncol., 1994, 10, 249.
33. Strong L. C., Williams W. R., Tainsky M A , "The Li-Fraumeni syndrome: from clinical epidemiology to molecular genetics". Am. J. of Epidem., 1992, 135, 190.
34. Hall J. M., Lee M. K., Newman B., Morrow J. E., Anderson L. A., Huey B. et al.: "Linkage of early onset breast cancer to chromosome 17q21". Science, 1990, 250, 1684.
35. Narod S. A., Feunteun J., Lynch H. T., Watson P., Conway T., Lynch J. et al.: "Familial breast-ovarian cancer locus on chromosome 17q21-q23". Lancet, 1991, 338, 82.
36. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavitigian S. et al.: "A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1". Science. 1994, 266, 66.
37. Anzai Y., Holinka C. F., Kuramoto H., Gurpide E.: "Stimulatory effect of 4-hydroxytamoxifen on proliferation of human endometrial adenocarcinoma cells (Ishikawa line)". Cancer Res., 1989, 49, 2362.
38. Hwang J. Y., Lin B. Y., Tang F. M., Yu W. C. Y.: "Tamoxifen stimulates human Papillomavirus type 16 gene expression and cell proliferation in a cervical cancer line". Cancer Res., 1992, 52, 6848.
39. Tripathy D.: "How long should adjuvant tamoxifen be continued". Oncology, 1994, 8, 25.
40. Tormey D. C., Jordan V. C.: "Long-term tamoxifen adjuvant therapy in node positive breast cancer: a metabolic and pilot clinical study". Breast Cancer Res. Treat., 1984, 4, 297.
41. Rutqvist L. E., Cedermark B., Glas U., Johansson H., Rotstein S., Skoog L. et al.: "Randomized trial of adjuvant tamoxifen in node negative postmenopausal breast cancer. Stockholm breast cancer study group". Acta Oncol., 1992, 31, 265.
42. Fisher B., Redmond C., Brown A., Fisher E. R., Wolmark N., Bowman D. et al.: "Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant breast and Bowel Project trial". J. Clin. Oncol., 1986, 4, 459.
43. Falkson H. C., Gray R., Wolberg W. H., Gillchrist K. W., Harris J. E., Tormey D. C. et al.: "Adjuvant trial of 12 cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study". J. Clin. Oncol., 1990, 8, 599.
44. Tormey D. C., Gray R., Abeloff M. D., Roseman D. L., Gilchrist K. W., Barylak E. J. et al.: "Adjuvant therapy with a doxorubicin regimen and long-term tamoxifen in premenopausal breast cancer patients: an Eastern Cooperative Oncology Group trial". J. Clin. Oncol., 1992, 10, 1848.
45. Fornander T., Cedeermark B., Mattsson A., Skoog L., Theve T., Askergren J. et al.: "Adjuvant tamoxifen in early breast cancer occurrence of new primary cancer". Lancet, 1989, 2, 117.
46. Osborne C. K., Coroando E. B., Robinson J. P.: "Human breast cancer in the athymic nude mouse. cytostatic effects of long-term antiestrogen therapy". Eur. J. Cancer Clin. Oncol., 1987, 23, 1189.
47. Gottardis M. M., Jordan V. C.: "Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration". Cancer res., 1988, 48, 5183.
48. Osborne C. K., Coronado E., Allred D. C., Wiebe V., Degregorio M.: "Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxife". J. Natl. Cancer Inst., 1991, 83, 1477.
49. Stewart H. J.: "The Scottish trial of adjuvant tamoxifen in node negative breast cancer, The Scottish Cancer Trials Breast Group". Monogr Natl. Cancer Inst., 1992, 11, 117.
50. Fisher B., Redmond C.: "Systemic therapy in node-negative patients: updated finding from the NSABP clinical trials". Monogr. Natl. Cancer Inst., 1992, 11, 105.